DHX9 and breast cancer: In ADAR1-dependent BC cell lines, the knockdown of DHX9 led to PKR activation and cell death, underscoring a cooperative role between ADAR1 and DHX9 in suppressing innate immune activation and promoting tumor cell survival (139–141).